Fresh Equities
CYNATA THERAPEUTICS LIMITED

CYNATA THERAPEUTICS LIMITED

ASX:CYP

Biotechnology

Live Capital Raise

CYNATA THERAPEUTICS LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10

Capital Raise History


Company Overview

Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. Former Names Senevens International Limited (SVN), 5/12/2008; Eco Quest Limited (ECQ), 15/11/2013.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

Level 3/62 Lygon St, Carlton VIC 3053, Australia

Biotechnology
Health Care

Quarterly Cash Flows
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Directors


Announcements, Interviews, News, and Presentations


More Companies Raising Right Now


Other Companies You Might Like

Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Archive

Support

This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.